SABS
USDSAB Biotherapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.140
High
$3.330
Low
$3.140
Volume
0.08M
Company Fundamentals
Market Cap
33.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.27M
Exchange
NCM
Currency
USD
52-Week Range
Related News
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Related Stocks
GPRO
GoPro Inc.
SGRY
Surgery Partners Inc.
IRM
Iron Mountain Incorporated (Delaware)Common Stock REIT
IMNM
Immunome Inc.
NLOP
Net Lease Office Properties Common Shares of Beneficial Interest
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.